Versatope Therapeutics
Mr. Barber has worked in the Life Science industry for more than 20 years and has raised over $500M in IPOs, secondary public offerings, private equity and venture capital financing. He and his team at the Prestar Group provide financial, human resources and operation services to early-stage biotechnology companies. He has successfully completed numerous strategic acquisitions and managed the post-transaction integration of acquisitions. He is a Certified Public Accountant and received his B.S. degree from Florida State University.
This person is not in any offices
Versatope Therapeutics
Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.